CanTx Overview
- Founded
-
2013
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
CanTx General Information
Description
Developer of ovarian cancer drug. The company develops drugs which destroys the cancer stem cells.
Contact Information
Website
www.can-tx.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Discovery
Primary Office
- New Haven, CT
- United States
CanTx Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
CanTx Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| David Brown Ph.D | Chief Scientific Officer | ||
| Andrew Heaton Ph.D | Vice President, Drug Discovery | ||
| Graham Kelly Ph.D | Founder |
CanTx Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|